• Clinical Insights: November 24, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ZokinvyTM (lonafarnib) Capsules – New Drug Approval – November 20, 2020 – The U.S. Food and Drug Administration approved ZokinvyTM (lonafarnib) capsules to reduce the risk of death… Read more »

  • Clinical Insights: November 17, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets – New Drug Approval – November 10, 2020 – Sebela Pharmaceuticals® announced that the U.S. Food and Drug Administration… Read more »

  • Clinical Insights: November 10, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval SesquientTM (fosphenytoin sodium) Injection – New Drug Approval – November 5, 2020 – Sedor Pharmaceuticals, LLC announced that the U.S. Food and Drug Administration (FDA) has approved SesquientTM… Read more »

  • Clinical Insights: November 4, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Bronchitol® (mannitol) Inhalation Powder – New Drug Approval – October 30, 2020 – Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group… Read more »

  • Clinical Insights: October 27, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Veklury® (remdesivir) Injection – New Drug Approval – October 22, 2020 – The U.S. Food and Drug Administration approved the antiviral drug Veklury® (remdesivir) for use in adult… Read more »

  • Connect with RxStrategies at the HCP 2020 Virtual Fall Hospital Pharmacy Conference

    The RxS team is looking forward to connecting with health care leaders during the HCP 2020 Virtual Fall Hospital Pharmacy Conference. If you are attending, be sure to stop by the RxStrategies’ virtual booth during the Virtual Supplier Showcase from October 26 – November 19. Contact Krista Scanlon at kscanlon@rxstrateiges.com to schedule a demo or… Read more »

  • Clinical Insights: October 20, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn) Injection – New Drug Approval – October 14, 2020 – The U.S. Food and Drug Administration approved InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn), a… Read more »

  • Celebrate National Pharmacy Week – October 18-24

    RxStrategies is are honored to recognize pharmacists and pharmacy technicians as they provide quality care in hospitals, health centers, pharmacies and other healthcare settings. Thank you for your invaluable contributions.   Learn more about the week >>

  • Clinical Insights: October 13, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage No new update. New Drug Recall and Safety Alerts No… Read more »

  • Clinical Insights: October 6, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Alkindi® Sprinkle (hydrocortisone) Oral Granules – New Orphan Drug Approval – September 29, 2020 – Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing… Read more »